pemigatinib
Ligand Summary
Pemigatinib inhibited FGFR1-3 phosphorylation and signaling and decreased cell viability in cancer cell lines with activating FGFR amplifications and fusions that resulted in constitutive activation of FGFR signaling.
UNII: Y6BX7BL23K
PubChem: 86705695
Guide to Pharmacology: 9767
ChEMBL: CHEMBL4297522
DrugCentral: 5390
LyCHI: QYT59LXCG4YV
Target Activities
8 Activities
Items per page:
10
1 – 8 of 8
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) | ||
---|---|---|---|---|---|---|
IC50 | ||||||
IC50 | ||||||
IC50 | ||||||
IC50 | ||||||
IC50 | ||||||
IC50 | INHIBITOR | |||||
IC50 | INHIBITOR | |||||
IC50 | INHIBITOR | |||||